Revolutionizing Infectious Disease Diagnostics

ONETest™ Platform

Unlocking the Future of Infectious Disease Management

At Fusion Genomics, we are on a mission to transform the landscape of infectious disease diagnostics. With our ground-breaking technologies and innovative solutions, we aim to revolutionize the way we detect, identify, and manage infectious diseases, ultimately saving lives and improving global health outcomes.

Introducing the ONETest™ – A Game-Changing Breakthrough

Imagine a single, easy-to-use, and cost-effective test that provides comprehensive pathogen detection and clinically relevant genomic information within a crucial window of time. This is now a reality with the ONETest™, our cutting-edge targeted metagenomics solution.

The ONETest™: Unleashing the Power of Genomics

At Fusion Genomics, we’ve combined two breakthrough technologies: our patented ONETest™ technology and full walk-away automation. This unique combination enables us to diagnose any and all infections with unparalleled precision and ease. Our ONETest™ platform offers a simplified, sample-to-result, massively multiplex, targeted metagenomic assay that detects the full range of human pathogens in a single test.

Proven Success, Global Validation

Our commitment to excellence is reinforced by successful collaborations with esteemed Key Opinion Leaders (KOLs) and validation studies with renowned institutions worldwide. Through partnerships with organizations such as the European CDC, the Canadian Food Inspection Agency, University of Florida Health, and Merck Sharp & Dohme, we have demonstrated the effectiveness and reliability of the ONETest™ in real-world scenarios.

Driving Adoption and Commercial Success

With a robust go-to-market strategy and strategic partnerships in place, we are primed to drive the adoption and commercial success of the ONETest™. Our track record of successful deployments, including a recent pilot study at Toronto Pearson International Airport, showcases the real-world effectiveness of our technology in detecting and identifying emerging infectious diseases.

Join Us on the Journey

We invite you to explore our website to learn more about our groundbreaking technology, validation studies, competitive advantages, and global impact. Together, let’s shape the future of infectious disease diagnostics and prevent avoidable suffering.

Invest in the Future of Infectious Disease Management

We are actively seeking strategic partnerships and investments to accelerate our mission and expand the reach of the ONETest™. Join us in revolutionizing infectious disease diagnostics and making a lasting impact on global health.

Contact us today to explore investment opportunities or to learn more about Fusion Genomics and the ONETest™.

For research use only.  Not intended for any animal or human therapeutic or diagnostic use.